Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On October 19, 2023, Culper Research issued a report on XPEL alleging that the Company had “grossly understated its reliance on Tesla,” and that Tesla’s decision to insource is a “death knell” for XPEL. The report also claimed that “the Company is concealing a massive undisclosed risk from its primary supplier which threatens to upend the Company’s entire reason for being.” Based on this news, shares of XPEL fell by more than 16% in value on October 19, 2023.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |
| GSK | GSK plc | April 07, 2025 | Join |
| NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
| MRK | Merck & Co., Inc. | April 14, 2025 | Join |